EcoDrugPlus

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSXMAG00000006743
Gene Symbol: ABCB1
4 Cross references
164 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSXMAG00000029657
Gene Symbol: ABCC1
3 Cross references
201 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSXMAG00000019243
Gene Symbol: ABCC8
3 Cross references
225 Possible Orthologues:

Atp-Binding Cassette Sub-Family C Member 9-Like

Ensembl ID : ENSXMAG00000017404
Gene Symbol: LOC102234902
3 Cross references
231 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSXMAG00000008520
Gene Symbol: ATP1A1
3 Cross references
181 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSXMAG00000011085
Gene Symbol: ATP1B2
3 Cross references
200 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSXMAG00000009281
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSXMAG00000005926
Gene Symbol: AXL
4 Cross references
187 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSXMAG00000008567
Gene Symbol: BRAF
3 Cross references
219 Possible Orthologues:

B2 Bradykinin Receptor-Like

Ensembl ID : ENSXMAG00000019784
Gene Symbol: LOC102216728
3 Cross references
147 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSXMAG00000021575
Gene Symbol: BCL2
3 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSXMAG00000009583
Gene Symbol: BCL2L1
4 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).